THE EDITORIAL PROCESS
American Journal of Pharmacotherapy and Pharmaceutical Sciences has a highly rigorous and unbiased double-blind peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel, and meaningful.
Decisions on accepting manuscripts for publication are solely based on the peer-review process, and the Editor’s discretion and the decision are final. The manuscript is sent for peer review to at least two external reviewers, and if required, it is sent to a third reviewer to act as a tie-breaker. A completed review by two reviewers recommending the acceptance of the manuscript for publication is mandatory.
In double-blind review process, the reviewers and authors are unaware of each other’s identity. The comments and suggestions (acceptance/rejection/amendments to the manuscript) received from reviewers are conveyed to the author anonymously. The author is requested to provide a point-by-point response to reviewers’ comments and submit a revised manuscript version. This process is repeated until reviewers and editors are satisfied with the manuscript.
Manuscripts accepted for publication are copy-edited for grammar, punctuation, print style, and format. Galley proofs are sent to the author. The author is expected to return the corrected proofs strictly within three days. It may not be possible to incorporate corrections received after that period. All the communication between the Journal and the author is completely online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online immediately on final acceptance.
Manuscripts that do not conform to the Author Guidelines or exceed the Maximums set for Articles may be returned to the author for technical modification without review. Authors need to resubmit the manuscript after complying with the requirements.
AJPPS uses EditorialAssist as its peer review tracking system. Manuscripts must be submitted online by the Corresponding Author at http://www.editorialassist.com/AJPPS/. You may be required to register as a new user with EditorialAssist upon your first visit. Login and registration procedures can be found on the website. EditorialAssist allows authors to track the progress of manuscript review in real time. Detailed, step-by-step instructions for submitting manuscripts can be found on the website. All correspondence regarding your manuscript should go through
EditorialAssist. Special Features, Appendices, and Supplementary Material can be accommodated and may contain highly interactive features or large databases. If in doubt contact the journal editor (firstname.lastname@example.org).
TERMS OF MANUSCRIPT CONSIDERATION
AJPPS ETHICS POLICY
AJPPS has developed an integrated ethics policy to guide decision-making across all submissions to the journal. The document is based on the recommendations on publication ethics policies for medical journals published by the World Association of Medical Editors (WAME).
Authors are required to review and adhere to the AJPPS Ethical Guidelines in full prior to submitting manuscripts to the Journal. Excerpts from the Policy are outlined below.
During the manuscript submission process, all authors will be required to confirm that the manuscript has not been previously published in any language anywhere and that it is not under simultaneous consideration by another journal. The policy regarding chemical compound disclosure centers on the data presented. If specific data relating to the study compound are reported, then the journal requires identification so that reviewers and readers can judge, based on general principles, whether the data are plausible and internally consistent, and to potentially allow future examination and/or validation of the results and conclusions reported. If, however, a library of compounds is used to generate correlations, such as in QSAR when the scope and diversity of the compounds are described, then it is possible that the specific chemical compositions of the compounds need not be identified, subject to the discretion of the reviewers and the editor.
CONFLICTS OF INTEREST
Authors will be required to declare all known conflicts of interest (or their absence) during the submission of a manuscript. This conflict declaration includes conflicts or potential conflicts of all listed authors. Declared conflicts will be published in the paper. In cases of doubt, the circumstance should be disclosed so that the editors may assess its significance.
Conflicts may be financial, intellectual, commercial, political, or personal. Financial interests may include employment, research funding (received or pending), stock or share ownership, patents, payment for lectures or travel, consultancies, nonfinancial support, or any fiduciary interest in a company.
The Copyright Revision Act of 1976 (US Public Law 94-533) requires that authors transfer their copyrights to the American Journal of Pharmacotherapy and Pharmaceutical Sciences in order to provide for the widest possible dissemination of professional and scientific literature. A Transfer of Copyright form must be submitted online with the manuscript. The Transfer of Copyright form for an accepted manuscript must be on file with the AJPPS Editorial Office prior to production for publication. The corresponding authors must sign the form on behalf of all authors. Copyright and disclosure forms are available for download from the author’s panel and should be uploaded as PDF files.
ORIGINALITY OF MANUSCRIPTS
Authors of manuscripts submitted to the AJPPS are obliged to present accurate representation of the research performed along with an objective discussion of the significance of their findings. The author’s submission should be original work that reflects research undertaken with integrity and honesty, and it must conform to the ethical practices outlined in the AJPPS Ethical Guidelines. Authors should be willing to reply to any reasonable request from editors, reviewers, and scientists for materials, methods, or data necessary for verification of the conclusions reported in the paper.
USE OF COPYRIGHTED TABLES AND FIGURES
A copy of the granted permission to use copyrighted figures and tables must be included with the submitted manuscript.
All submissions will be reviewed anonymously by at least two independent reviewers. Authors are encouraged to submit names and email addresses of expert reviewers, but selection remains a prerogative of the editors. Authors may include supplementary notes to facilitate the review process. If an accepted paper is cited that has not yet appeared in print and is required for evaluation of the submitted manuscript, authors should provide an electronic version for use by the reviewers. Authors are responsible for all statements in their work, including changes made by the copyeditor after a manuscript is accepted.